42 CFR Part 82 — Methods for Conducting Dose Reconstruction Under the Energy Employees Occupational Illness Compensation Program Act of 2000
Subpart A — Introduction
Subpart B — Definitions
Subpart C — Dose Reconstruction Process
- § 82.10— Overview of the dose reconstruction process.
- § 82.11— For which claims under EEOICPA will NIOSH conduct a dose reconstruction?
- § 82.12— Will it be possible to conduct dose reconstructions for all claims?
- § 82.13— What sources of information may be used for dose reconstructions?
- § 82.14— What types of information could be used in dose reconstructions?
- § 82.15— How will NIOSH evaluate the completeness and adequacy of individual monitoring data?
- § 82.16— How will NIOSH add to monitoring data to remedy limitations of individual monitoring and missed dose?
- § 82.17— What types of information could be used to supplement or substitute for individual monitoring data?
- § 82.18— How will NIOSH calculate internal dose to the primary cancer site(s)?
- § 82.19— How will NIOSH address uncertainty about dose levels?
Subpart D — Reporting and Review of Dose Reconstruction Results
- § 82.25— When will NIOSH report dose reconstruction results, and to whom?
- § 82.26— How will NIOSH report dose reconstruction results?
- § 82.27— How can claimants obtain reviews of their NIOSH dose reconstruction results by NIOSH?
- § 82.28— Who can review NIOSH dose reconstruction files on individual claimants?
Subpart E — Updating the Scientific Elements Underlying Dose Reconstructions
- § 82.30— How will NIOSH inform the public of any plans to change scientific elements underlying the dose reconstruction process to maintain methods reasonably current with scientific progress?
- § 82.31— How can the public recommend changes to scientific elements underlying the dose reconstruction process?
- § 82.32— How will NIOSH make changes in scientific elements underlying the dose reconstruction process, based on scientific progress?
- § 82.33— How will NIOSH inform the public of changes to the scientific elements underlying the dose reconstruction process?